{"id":"placebo-of-modafinil","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Dizziness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"As a placebo, it does not interact with the body in any way, serving as a control group in clinical trials. This allows researchers to isolate the effects of the active treatment being tested.","oneSentence":"Placebo does not have a known mechanism of action, as it is an inert substance.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:28:17.147Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of narcolepsy, sleep apnea, and shift work sleep disorder"}]},"trialDetails":[{"nctId":"NCT07263022","phase":"PHASE3","title":"Cognitive Strategies in Early Psychosis 2","status":"NOT_YET_RECRUITING","sponsor":"University of Minnesota","startDate":"2026-04-13","conditions":"Psychosis, Schizophrenia Disorder, Schizoaffective Disorder","enrollment":24},{"nctId":"NCT06404099","phase":"PHASE2","title":"RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Duke University","startDate":"2024-08-12","conditions":"Long COVID, Long COVID-19, Hypersomnia","enrollment":361},{"nctId":"NCT06404086","phase":"PHASE2","title":"RECOVER-SLEEP: Platform Protocol","status":"COMPLETED","sponsor":"Duke University","startDate":"2024-07-31","conditions":"Long COVID, Long COVID-19, Hypersomnia","enrollment":830},{"nctId":"NCT01988883","phase":"EARLY_PHASE1","title":"Modafinil and Cognitive Function in POTS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2014-10","conditions":"Postural Tachycardia Syndrome","enrollment":20},{"nctId":"NCT06041048","phase":"PHASE4","title":"Investigation of Locus Coeruleus Function in Sustained Attention","status":"RECRUITING","sponsor":"University of California, Davis","startDate":"2023-10-01","conditions":"Attention - no Condition is Being Assessed - Healthy Adults","enrollment":40},{"nctId":"NCT00262470","phase":"PHASE1, PHASE2","title":"Treatment of Orthostatic Intolerance","status":"ACTIVE_NOT_RECRUITING","sponsor":"Satish R. Raj","startDate":"1997-04","conditions":"Tachycardia, Chronic Orthostatic Intolerance","enrollment":150},{"nctId":"NCT00373672","phase":"PHASE4","title":"Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2006-08","conditions":"Schizophrenia, Schizoaffective Disorder","enrollment":58},{"nctId":"NCT05351541","phase":"PHASE1, PHASE2","title":"Psilocybin Therapy for Chronic Low Back Pain","status":"RECRUITING","sponsor":"Joshua Woolley, MD, PhD","startDate":"2023-12-01","conditions":"Chronic Low-back Pain","enrollment":30},{"nctId":"NCT01781468","phase":"PHASE3","title":"Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2013-06-21","conditions":"Fatigue","enrollment":328},{"nctId":"NCT02855229","phase":"","title":"Novel Cross-Species Neurophysiological Assays of Reward and Cognitive Domains","status":"COMPLETED","sponsor":"Mclean Hospital","startDate":"2020-08-15","conditions":"Translational Electrophysiology","enrollment":222},{"nctId":"NCT06619665","phase":"PHASE1","title":"A Study of MK-6552 in Sleep Deprived Healthy Participants (MK-6552-003)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-03-19","conditions":"Healthy, Narcolepsy","enrollment":18},{"nctId":"NCT01330446","phase":"PHASE1, PHASE2","title":"Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2011-05-19","conditions":"Head And Neck Cancer, Fatigue","enrollment":26},{"nctId":"NCT03914118","phase":"PHASE2","title":"Modafinil to Prevent Postoperative Cognitive Decline","status":"COMPLETED","sponsor":"The Cooper Health System","startDate":"2008-01-01","conditions":"Postoperative Cognitive Dysfunction","enrollment":137},{"nctId":"NCT05675098","phase":"EARLY_PHASE1","title":"Central Nervous System Stimulants and Physical Function in Children With Cerebral Palsy","status":"NOT_YET_RECRUITING","sponsor":"Kuwait University","startDate":"2023-05-01","conditions":"Neurodevelopmental Disorders, Cerebral Palsy","enrollment":30},{"nctId":"NCT02896712","phase":"PHASE2","title":"Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2016-11-18","conditions":"Cocaine-Related Disorders","enrollment":118},{"nctId":"NCT02538744","phase":"PHASE1","title":"Complementary Combination Therapy for Cocaine Dependence","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2015-08","conditions":"Cocaine Dependence","enrollment":45},{"nctId":"NCT03616717","phase":"PHASE4","title":"Modafinil Effects on EEG Biomarkers of Reward and Motivation","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2018-10-16","conditions":"Healthy Adults","enrollment":23},{"nctId":"NCT00893789","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury","status":"TERMINATED","sponsor":"Cephalon, Inc.","startDate":"2009-04-30","conditions":"Traumatic Brain Injury","enrollment":117},{"nctId":"NCT00838981","phase":"PHASE1, PHASE2","title":"Pharmacotherapy & CM for Opioid and Cocaine Dependence","status":"COMPLETED","sponsor":"Yale University","startDate":"2008-05","conditions":"Cocaine Dependence","enrollment":91},{"nctId":"NCT03083132","phase":"PHASE2","title":"Modafinil for Freezing of Gait (FOG) in Parkinson's Disease (PD)","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"2017-06-13","conditions":"Parkinson Disease","enrollment":21},{"nctId":"NCT01032200","phase":"PHASE2","title":"Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2010-08-01","conditions":"Brain Tumors, Nervous System Tumors, Cognition Disorders","enrollment":54},{"nctId":"NCT01381718","phase":"PHASE2","title":"Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor","status":"COMPLETED","sponsor":"University of South Florida","startDate":"2011-08","conditions":"Brain and Central Nervous System Tumors, Cognitive/Functional Effects, Fatigue","enrollment":112},{"nctId":"NCT01096680","phase":"PHASE2","title":"Pharmacodynamic Profile of SPD489 in Healthy Adult Males Undergoing a Nocturnal Period of Acute Sleep Loss","status":"COMPLETED","sponsor":"Shire","startDate":"2010-04-05","conditions":"Sleep Deprivation","enrollment":135},{"nctId":"NCT03522506","phase":"PHASE1","title":"A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-925 Study in Sleep-Deprived Healthy Adults","status":"COMPLETED","sponsor":"Takeda","startDate":"2018-05-09","conditions":"Healthy Volunteers","enrollment":20},{"nctId":"NCT03624920","phase":"PHASE2","title":"Safety and Efficacy of THN102 in Patients With Parkinson's Disease and Excessive Daytime Sleepiness","status":"COMPLETED","sponsor":"Theranexus","startDate":"2018-07-12","conditions":"Parkinson Disease","enrollment":77},{"nctId":"NCT03185065","phase":"PHASE3","title":"Treatment of Fatigue With Methylphenidate, Modafinil and Amantadine in Multiple Sclerosis","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2017-10-04","conditions":"Fatigue in Multiple Sclerosis","enrollment":141},{"nctId":"NCT02821715","phase":"PHASE2","title":"Safety and Efficacy of THN102 on Sleepiness in Narcoleptic Patients","status":"COMPLETED","sponsor":"Theranexus","startDate":"2016-09","conditions":"Narcolepsy","enrollment":51},{"nctId":"NCT00142818","phase":"PHASE2","title":"Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence","status":"COMPLETED","sponsor":"Kyle Kampman","startDate":"2006-02","conditions":"Alcohol-Related Disorders, Alcoholism, Cocaine-Related Disorders","enrollment":164},{"nctId":"NCT03424681","phase":"PHASE2","title":"Modafinil for the Treatment of Alcohol Use Disorders","status":"COMPLETED","sponsor":"The Mind Research Network","startDate":"2017-12-11","conditions":"Alcohol Use Disorder","enrollment":12},{"nctId":"NCT01913327","phase":"PHASE4","title":"Antipsychotic Effects on Brain Function in Schizophrenia","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2013-04","conditions":"Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder","enrollment":4},{"nctId":"NCT01019187","phase":"PHASE2","title":"Cognitive Behavioral Therapy With or Without Armodafinil in Treating Cancer Survivors With Insomnia and Fatigue After Chemotherapy","status":"COMPLETED","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2009-06","conditions":"Unspecified Adult Solid Tumor, Protocol Specific","enrollment":226},{"nctId":"NCT04317001","phase":"PHASE3","title":"Treatment for Cognitive Impairment in Depression","status":"WITHDRAWN","sponsor":"Stanford University","startDate":"2018-12-01","conditions":"Major Depressive Disorder","enrollment":""},{"nctId":"NCT00469508","phase":"PHASE2","title":"Modafinil vs Placebo for the Treatment of Methamphetamine Dependence","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2007-04","conditions":"Methamphetamine Dependence","enrollment":71},{"nctId":"NCT01317550","phase":"NA","title":"A Study for Reducing Symptom Burden Produced by Chemoradiation Treatment for Non Small Cell Lung Cancer by Minocycline and Armodafinil","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2011-07","conditions":"Lung Cancer","enrollment":14},{"nctId":"NCT00057707","phase":"PHASE1","title":"Effects of Modafinil on Brain Function in Patients With Schizophrenia","status":"COMPLETED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2003-03-26","conditions":"Schizophrenia, Schizoaffective Disorder","enrollment":176},{"nctId":"NCT01896128","phase":"PHASE2","title":"Combining Armodafinil With Neuro-rehabilitation to Improve Neurological Recovery and Reduce Disability Post-Stroke","status":"COMPLETED","sponsor":"Burke Rehabilitation Hospital","startDate":"2008-01","conditions":"Stroke, Cerebrovascular Accident, Hemiparesis","enrollment":19},{"nctId":"NCT03620253","phase":"PHASE3","title":"Modafinil's Effects on Cognition in Remitted MDD","status":"TERMINATED","sponsor":"Unity Health Toronto","startDate":"2018-10-15","conditions":"Major Depressive Disorder, Cognitive Impairment","enrollment":9},{"nctId":"NCT03893032","phase":"PHASE2","title":"Enhancing Operational Performance in Healthy Rested Soldiers With Pharmacological Stimulants","status":"UNKNOWN","sponsor":"United States Army Aeromedical Research Laboratory","startDate":"2019-07-17","conditions":"Cognition","enrollment":80},{"nctId":"NCT02494102","phase":"PHASE4","title":"Evaluation of Modafinil vs Placebo for Treatment of Anesthesia Delayed Emergence in Obstructive Sleep Apnea","status":"TERMINATED","sponsor":"Milton S. Hershey Medical Center","startDate":"2016-02","conditions":"Obstructive Sleep Apnea, Delayed Emergence From Anesthesia","enrollment":105},{"nctId":"NCT03426202","phase":"NA","title":"The Effect of Modafinil on Affective and Cognitive Processing","status":"UNKNOWN","sponsor":"University of Electronic Science and Technology of China","startDate":"2018-01-01","conditions":"Healthy","enrollment":60},{"nctId":"NCT00751023","phase":"PHASE4","title":"Effects of Modafinil in Methamphetamine Dependence","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2009-02","conditions":"Methamphetamine Dependence","enrollment":40},{"nctId":"NCT02155257","phase":"PHASE4","title":"Pain Expectations in Subjects With Osteoarthritis","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2014-07","conditions":"Osteoarthritis","enrollment":30},{"nctId":"NCT02468856","phase":"PHASE1","title":"Effect of Armodafinil on Simulated Driving","status":"COMPLETED","sponsor":"University of Florida","startDate":"2017-05-21","conditions":"Healthy Volunteers","enrollment":12},{"nctId":"NCT02478580","phase":"PHASE3","title":"Armodafinil (Nuvigil), Postoperative Recovery of OSA (Obstructive Sleep Apnea) and Obese Patients","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2011-08","conditions":"Obesity, Premature Recovery From Anesthesia","enrollment":67},{"nctId":"NCT01011218","phase":"PHASE2","title":"Management of Insomnia in Breast Cancer Patients","status":"COMPLETED","sponsor":"Stanford University","startDate":"2011-01","conditions":"Insomnia, Fatigue","enrollment":70},{"nctId":"NCT00218036","phase":"PHASE2","title":"Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8","status":"TERMINATED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2006-07","conditions":"Cocaine Abuse, Opiate Dependence","enrollment":54},{"nctId":"NCT01092780","phase":"PHASE1","title":"Pharmacodynamics and Efficacy of MK-7288 in Adults With Sleep Apnea (MK-7288-010)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2010-05-26","conditions":"Apnea, Sleep","enrollment":56},{"nctId":"NCT03469089","phase":"PHASE1","title":"Touchscreen-based Cognitive Tests in Healthy Volunteers","status":"UNKNOWN","sponsor":"University of Eastern Finland","startDate":"2018-03-12","conditions":"Cognitive Symptom, Schizophrenia","enrollment":16},{"nctId":"NCT02376257","phase":"PHASE2","title":"Improving Therapeutic Learning in Depression: Proof of Concept","status":"COMPLETED","sponsor":"Boston University Charles River Campus","startDate":"2014-09-16","conditions":"Major Depressive Disorder","enrollment":36},{"nctId":"NCT01746043","phase":"PHASE2","title":"A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2013-02","conditions":"Esophageal Cancer","enrollment":22},{"nctId":"NCT00129285","phase":"PHASE2","title":"Modafinil Treatment for Cocaine-Dependent Individuals","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2004-07","conditions":"Cocaine-Related Disorders","enrollment":210},{"nctId":"NCT00267332","phase":"PHASE3","title":"Modafinil in Opioid Induced Sedation","status":"TERMINATED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2006-01","conditions":"Cancer, Pain","enrollment":90},{"nctId":"NCT01965925","phase":"PHASE4","title":"Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2014-01","conditions":"Bipolar Disorder","enrollment":18},{"nctId":"NCT00368290","phase":"PHASE2","title":"Modafinil Treatment for Cocaine Dependence and HIV High-Risk Behavior","status":"COMPLETED","sponsor":"Kyle Kampman","startDate":"2006-09","conditions":"Cocaine Dependence","enrollment":94},{"nctId":"NCT00859573","phase":"PHASE2","title":"Modafinil for Methamphetamine Dependence","status":"TERMINATED","sponsor":"University of Arkansas","startDate":"2009-04","conditions":"Methamphetamine Dependence","enrollment":9},{"nctId":"NCT00825227","phase":"PHASE2","title":"Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents","status":"TERMINATED","sponsor":"Cephalon","startDate":"2008-12","conditions":"Fatigue, Chemotherapy Side Effects","enrollment":10},{"nctId":"NCT00423943","phase":"PHASE4","title":"Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2005-09","conditions":"Schizophrenia, Schizoaffective Disorder","enrollment":33},{"nctId":"NCT00711464","phase":"PHASE4","title":"Modafinil Effects on Cognition in Schizophrenia Patients","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2008-05","conditions":"Schizophrenia","enrollment":29},{"nctId":"NCT02552303","phase":"NA","title":"The Treatment of Insomnia Comorbid With Sleep Disordered Breathing Using Armodafinil and/or Cognitive Behavioral Therapy for Insomnia","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2014-04","conditions":"Sleep Apnea, Insomnia","enrollment":39},{"nctId":"NCT00218062","phase":"PHASE2","title":"Effectiveness of Modafinil and D-amphetamine in Treating Cocaine Dependent Individuals","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2006-03","conditions":"Cocaine-Related Disorders","enrollment":73},{"nctId":"NCT03182413","phase":"PHASE1","title":"Impact of THN102 on Attention, Wakefulness and Cognitive Performance During Total Sleep Deprivation","status":"COMPLETED","sponsor":"Theranexus","startDate":"2015-09","conditions":"Sleep Deprivation","enrollment":20},{"nctId":"NCT00218023","phase":"PHASE2","title":"Medications for Stopping Cocaine Dependence and Preventing Relapse","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2006-03","conditions":"Cocaine Abuse, Cocaine-Related Disorders","enrollment":101},{"nctId":"NCT00258479","phase":"PHASE1","title":"Safety of Combining Modafinil and Nicotine Replacement Therapy in Treating Nicotine Dependent Adolescents","status":"COMPLETED","sponsor":"Catherine Martin, MD","startDate":"2003-06","conditions":"Tobacco Use Disorder","enrollment":24},{"nctId":"NCT00118378","phase":"PHASE4","title":"Effectiveness of Modafinil for Treating Fatigue in Adults With HIV/AIDS","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2004-12","conditions":"HIV Infections, Fatigue","enrollment":115},{"nctId":"NCT00520286","phase":"PHASE2","title":"Phase 2, Multi-Center Trial of Modafinil for Methamphetamine Dependence","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2007-12","conditions":"Methamphetamine Dependence","enrollment":210},{"nctId":"NCT02151253","phase":"PHASE2, PHASE3","title":"Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia","status":"COMPLETED","sponsor":"Duke University","startDate":"2011-05","conditions":"Nocturia, Daytime Sleepiness","enrollment":81},{"nctId":"NCT01460628","phase":"PHASE4","title":"Effect of Nuvigil on Fatigue","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2011-10","conditions":"Menopause","enrollment":25},{"nctId":"NCT01091974","phase":"PHASE2","title":"Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2008-02","conditions":"Insomnia, Fatigue, Breast Cancer","enrollment":138},{"nctId":"NCT01638403","phase":"PHASE3","title":"Effects of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy.","status":"COMPLETED","sponsor":"Bioprojet","startDate":"2010-11","conditions":"Treatment of Excessive Daytime Sleepiness in Narcolepsy","enrollment":180},{"nctId":"NCT00223691","phase":"PHASE1","title":"Treatment of Orthostatic Hypotension in Autonomic Failure","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2002-03","conditions":"Autonomic Failure, Orthostatic Hypotension","enrollment":389},{"nctId":"NCT00265278","phase":"PHASE1","title":"Assessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1","status":"UNKNOWN","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2005-03","conditions":"Amphetamine-Related Disorders","enrollment":16},{"nctId":"NCT02028260","phase":"PHASE3","title":"Modafinil Versus Placebo for Hypoactive Delirium in the Critically Ill","status":"WITHDRAWN","sponsor":"Brigham and Women's Hospital","startDate":"2014-01","conditions":"Delirium, Respiratory Failure","enrollment":""},{"nctId":"NCT01085903","phase":"PHASE2","title":"Identifying and Treating Arousal Related Deficits in Neglect and Dysphagia","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"2010-03","conditions":"Spatial Neglect, Dysphagia","enrollment":28},{"nctId":"NCT00766467","phase":"PHASE2","title":"A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas","status":"COMPLETED","sponsor":"Eudocia Quant Lee, MD","startDate":"2008-09","conditions":"Malignant Glioma","enrollment":81},{"nctId":"NCT01305408","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder","status":"COMPLETED","sponsor":"Cephalon","startDate":"2011-03","conditions":"Depression","enrollment":399},{"nctId":"NCT01072630","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder","status":"COMPLETED","sponsor":"Cephalon","startDate":"2010-03","conditions":"Depression","enrollment":492},{"nctId":"NCT01072929","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder","status":"COMPLETED","sponsor":"Cephalon","startDate":"2010-01","conditions":"Depression","enrollment":433},{"nctId":"NCT00233090","phase":"PHASE2","title":"Post-Traumatic Brain Injury (Post-TBI) Fatigue and Its Treatment","status":"TERMINATED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2005-07","conditions":"Fatigue","enrollment":21},{"nctId":"NCT02603861","phase":"PHASE1","title":"A Study of LY3154207 on Sleep in Healthy Male Participants","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2015-11","conditions":"Healthy","enrollment":16},{"nctId":"NCT01951508","phase":"EARLY_PHASE1","title":"Effects of Methylphenidate, Modafinil, and MDMA on Emotion-processing in Humans: A Pharmaco-fMRI Study","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2013-10","conditions":"Healthy, Substance-related Disorder, Mood Disorder","enrollment":24},{"nctId":"NCT01169753","phase":"NA","title":"Nuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia Patients","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2011-05","conditions":"Chronic Myeloid Leukemia","enrollment":1},{"nctId":"NCT00042848","phase":"PHASE3","title":"Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer","status":"COMPLETED","sponsor":"Gary Morrow","startDate":"2002-08","conditions":"Fatigue, Unspecified Adult Solid Tumor, Protocol Specific","enrollment":837},{"nctId":"NCT00591019","phase":"PHASE1","title":"Use of Modafinil in the Treatment of Tinnitus","status":"TERMINATED","sponsor":"University of Arkansas","startDate":"2006-08","conditions":"Tinnitus","enrollment":7},{"nctId":"NCT01800097","phase":"PHASE3","title":"Treatment of Post Stroke Fatigue With a Wakefulness Promoting Agent","status":"TERMINATED","sponsor":"Herlev Hospital","startDate":"2012-10","conditions":"Stroke, Post Stroke Fatigue","enrollment":41},{"nctId":"NCT00555347","phase":"PHASE2, PHASE3","title":"Use of Armodafinil for Fatigue in Sarcoidosis","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2007-10","conditions":"Sarcoidosis, Fatigue, Sleepiness","enrollment":20},{"nctId":"NCT00620659","phase":"PHASE2","title":"Treatment of Refractory Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome (OSA/HS) Using Nasal Continuous Positive Airway Pressure (nCPAP) Therapy (0249-015)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2008-02","conditions":"Sleep Apnea, Obstructive, Hypopnea Syndrome, Excessive Daytime Sleepiness","enrollment":125},{"nctId":"NCT01219673","phase":"PHASE1, PHASE2","title":"Symptom Burden in Head and Neck Cancer","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2013-03","conditions":"Head And Neck Cancer","enrollment":1},{"nctId":"NCT01461174","phase":"PHASE1","title":"Effects of Donepezil and Memantine on Cognitive Functions After a Sleep Deprivation Challenge in Healthy Volunteers","status":"COMPLETED","sponsor":"Qualissima","startDate":"2011-11","conditions":"Healthy","enrollment":36},{"nctId":"NCT00678691","phase":"PHASE4","title":"An Eight Week, Double-Blind Efficacy Study of Armodafinil Augmentation to Alleviate Fibromyalgia Fatigue","status":"COMPLETED","sponsor":"State University of New York - Upstate Medical University","startDate":"2007-08","conditions":"Fibromyalgia, Primary","enrollment":55},{"nctId":"NCT01160380","phase":"PHASE3","title":"A Study of the Effectiveness of Armodafinil to Treat Cancer-Related Fatigue in Patients With Multiple Myeloma","status":"COMPLETED","sponsor":"Oncotherapeutics","startDate":"2010-06","conditions":"Fatigue, Multiple Myeloma","enrollment":50},{"nctId":"NCT00737204","phase":"PHASE4","title":"Effectiveness of Armodafinil for Treating Fatigue in Adults With HIV/AIDS","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2008-06","conditions":"HIV Infections, Fatigue","enrollment":70},{"nctId":"NCT00424931","phase":"PHASE2","title":"A Safety and Effectiveness Study of a Single Dose of JNJ-17216498 in Patients With Narcolepsy","status":"COMPLETED","sponsor":"Alza Corporation, DE, USA","startDate":"2007-01","conditions":"Narcolepsy","enrollment":16},{"nctId":"NCT00107809","phase":"PHASE3","title":"Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome","status":"COMPLETED","sponsor":"Cephalon","startDate":"2004-10","conditions":"Sleep Apnea, Obstructive","enrollment":140},{"nctId":"NCT00343811","phase":"PHASE3","title":"Study to Evaluate the Efficacy of Modafinil Treatment in Patients With Attention Deficit Hyperactivity Disorder (ADHD) Who Are Responders to Modafinil Treatment","status":"COMPLETED","sponsor":"Cephalon","startDate":"2006-06","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":120},{"nctId":"NCT02071615","phase":"NA","title":"Effects of Modafinil, Caffeine and Methylphenidate in Healthy Volunteers","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2013-08","conditions":"Healthy","enrollment":48},{"nctId":"NCT01903824","phase":"PHASE1","title":"Pharmacokinetics and Pharmacodynamics (PK/PD) of CEP-26401 in Healthy Subjects","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2013-08","conditions":"Cognitive Impairment","enrollment":40},{"nctId":"NCT01348607","phase":"PHASE2","title":"Methylphenidate HCl or Modafinil in Treating Young Patients With Excessive Daytime Sleepiness After Cancer Therapy","status":"TERMINATED","sponsor":"University of South Florida","startDate":"2010-07","conditions":"Central Nervous System Tumor, Pediatric, Fatigue, Specific Disorders of Sleep","enrollment":1},{"nctId":"NCT02051153","phase":"NA","title":"Neurochemical Modulation Cognitive Performance and Subjective Wellbeing In Healthy Controls","status":"COMPLETED","sponsor":"Cambridge University Hospitals NHS Foundation Trust","startDate":"2009-10","conditions":"Cognitive Performance, Creativity, Motivation","enrollment":64},{"nctId":"NCT01400958","phase":"PHASE2","title":"Nuvigil or Placebo in Newly Diagnosed Malignant Glioma","status":"TERMINATED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2010-12","conditions":"Malignant Glioma","enrollment":6},{"nctId":"NCT00981084","phase":"PHASE2, PHASE3","title":"Impact of Armodafinil on Neurocognition and Cognitive Fatigue in Multiple Sclerosis (MS)","status":"COMPLETED","sponsor":"University of Missouri, Kansas City","startDate":"2009-09","conditions":"Multiple Sclerosis","enrollment":33}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo of Modafinil","genericName":"Placebo of Modafinil","companyName":"Sanofi","companyId":"sanofi","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo does not have a known mechanism of action, as it is an inert substance. Used for Treatment of narcolepsy, sleep apnea, and shift work sleep disorder.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}